If you think this has been an unbelievable week of news, try telling it to Joe Berti. Mr. Berti traveled to Boston for that city's marathon and crossed the finish line seconds before the first bomb exploded. He was OK and he went home to Texas, where he was close enough to a fertilizer plant to see it explode on Wednesday night. Some people might feel star-crossed at that point, but Mr. Berti considers himself lucky.
It's MORNING EDITION. Transcript provided by NPR, Copyright NPR.
All morning we have been following the extraordinary events in Boston, where a manhunt is underway for one of the two suspects in the Boston Marathon bombing. The brother of the young man the police are searching for, his brother was killed in a shootout last night with police. Meanwhile, this American city, the city of Boston and its surrounding neighborhoods are in total lockdown.
Steve Inskeep speaks with NPR's Scott Horsley, who has the White House perspective on news of the Boston Marathon bombings manhunt. NPR has confirmed that the two suspects were from Chechnya. For insights on that region, Morning Edition talks with Matt Rojansky, deputy director of the Russia and Eurasia program at the Carnegie Endowment for International Peace.
Steve Inskeep talks to NPR's Corey Flintoff in Moscow for reaction to news that Boston Marathon bombing suspects are from Chechnya. One suspect has been killed and the other is on the run. Authorities have encouraged Boston-area residents to shelter in place.
Steve Inkseep and David Greene talk to NPR's Tom Gjelten about the latest in the investigation of the Boston Marathon bombings. Dr. David Schoenfeld of Beth Israel Deaconess Medical Center in Boston talks about one of the bombing suspects being taken to that facility. That suspect died, the other is on the run.
An international dream team of flu experts assembled in China today.
Underscoring the urgency that public health agencies feel about the emergence of a new kind of bird flu, the team is headed by Dr. Keiji Fukuda, the World Health Organization's top influenza scientist.
Before he left Geneva, Fukuda explained the wide-open nature of the investigation in an interview with NPR.